doi: 10.1210/CLINEM/DGAA072 106 VetrugnoLDeanaCDa PortoABoeroEBelliniVBiasucciDGet al
Back SE, Gray K, Santa Ana E, Jones JL, Jarnecke AM, Joseph JE, et al
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of pharmacological agents with both glucose-lowering and weight-reducing effects
Below is a look at how dosing progresses across the most commonly used GLP-1 medications in weight-loss care
UAN: 430-0000-18-049-H01-P Credits: 2.0 hours (0.20 ceu) Type of Activity: Knowledge TARGET AUDIENCE: This accredited activity is targeted to pharmacists
Regional Analysis: The regions covered are North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America